Rare diseases
Investigational molecules
Locations
Ole Maaloees Vej 3, 2200 Copenhagen, Denmark
Curasight A/S is active in uPAR PET imaging research for untreated, localised prostate cancer, with interest in diagnostic performance and lesion characterisation in clinically defined disease.
The sponsor’s work in this area centres on improving tumour detection and supporting more precise risk stratification in early-stage prostate cancer.
Curasight A/S runs clinical trials in conditions such as Prostate cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
